This study reported no difference in the primary outcome of LGA infants, but reduced neonatal hypoglycemia, jaundice, and respiratory distress in the cohort treated to tighter targets at the expense of higher frequency of insulin used and increased obstetric interventions. This evidence concerns the gene INS and Hypoglycemia.